Methyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 98%, 1g

(R)-4-TERT-BUTOXY-4-OXO-2-PHENYLBUTANOIC ACID, 97.0%, 250mg

Nalpha-(tert-Butoxycarbonyl)-tele-(p-toluenesulfonyl)-L-histidine>98.0%(T)25g

{2-[(1-methyl-1H-tetrazol-5-yl)thio]ethyl}amine hydrochloride, 95.0%, 1g

1-METHYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7-OL, 95.0%, 250mg

3-Bromo-2-(trifluoromethyl)imidazo[1,2-b]pyridazine, 95.0%, 5g

5-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 500mg

(3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one, 98%, 10g

GC capillary column ROTI®Cap-5, 15 m, 0.53 mm, 0.50 µm, 1 Piece(s)

1-(Bromomethyl)-3,5-dichlorobenzene, 95.0%, 2.5g

2-Iodo-p-xylene, 95.0%, 1g

3-Isobutyl-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

(3-Chloro-5-fluorobenzyl)hydrazine hydrochloride, 97%, 100mg